The non-canonical Collagen I-DDR1 signaling regulating protein synthesis during metastasis
- Institution
- CEDARS-SINAI MEDICAL CENTER, CA
- Principal investigator
- Mark E. Alonzo
- Funding
- $43K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The activation of signaling tumor cells via the tumor micrenvironment (TME) to undergo metastasis in bladder cancer is understudied. Clinically, increased Col I deposition correlates with bladder cancer progression (i.e. increasing tumor stage). Our published study demonstrated that Col I induces bladder tumor cells to invade and colonize the lung through Discoidin Domain Receptor 1 (DDR1) pathway. Yet, increase Col deposition is known to cause nutrient deprivation which is unsustainable for tumor growth. Tumors can adapt to these increasingly harsh environment by downregulating protein synthesis – a metabolically expensive homeostatic process. Interestingly, this downregulation of protein synthesis has also been shown to promote resistance to anoikis, cell death resulting from extracellular matrix detachment, which cancer cells must overcome when they undergo metastasis. To our knowledge, whether collagen outside-in signaling senses nutrient deprivation and thereafter reduces energy expenditure by attentuating protein synthesis has yet to be investigated. Interestingly, my pilot studies show two independent, yet complementary non-canonical mechanisms of downregulating protein synthesis, which involves Col I-DDR1 interaction. I now propose to 1) interrogate these two mechanisms that downregulate protein synthesis and 2) how this Col I-DDR1 mediated downregulation of protein synthesis affects the efficiency of cancer metastasis. Knowledge gained from the success of this proposal will yield newer insights on Col I-DDR1 interaction in promoting cancer cell survival and metastasis in bladder cancer.
LOADING MOONBASE SCORE
Questions for CEDARS-SINAI MEDICAL CENTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Cedars-Sinai Medical Center68
Nucleocapsid bioparticles eliciting multi-pronged attack on tumor metastases
Lali K Medina-Kauwe · $382K · 2022–2027
- NIH · Cedars-Sinai Medical Center51
Characterizing Older Mexican (American) Participation in Activity Digitally, Reliably, and Ecologically with the CART Platform (COMPADRE CART): Implications for Cognition and ADRD
Zachary Beattie · $716K · 2022–2027
- NIH · Cedars-Sinai Medical Center46
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease
Gil Y Melmed · $548K · 2021–2026